CAPR Investors Left in the Dark: The Hidden Red Flags Behind Capricor’s Securities Fraud Storm
Capricor Therapeutics faces a securities fraud class action with a September 28 deadline. Allegations of misleading clinical trial data and regulatory claims have erased market...
